Figure 1From: Both SEPT2 and MLL are down-regulated in MLL-SEPT2therapy-related myeloid neoplasia Box-plots of normalized expression values for SEPT2 (A) and MLL (B) in subgroups of myeloid malignancies and control samples. Asterisks denote significant differences when compared with the normal control group. The combined expression of MLL-SEPT2 and MLL or SEPT2 was significantly lower in MLL-SEPT2 patients compared to all other groups (see Table 1 for significance values).Back to article page